Request Demo
Last update 11 Sep 2025
Anti-CD19, Anti-CD20 CAR T Cells(Universitätsspital Basel)
Last update 11 Sep 2025
Overview
Basic Info
Drug Type CAR-T |
Synonyms- |
Target |
Action modulators |
Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators), CD20 modulators(B-lymphocyte antigen CD20 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with Anti-CD19, Anti-CD20 CAR T Cells(Universitätsspital Basel)NCT07166549
A Phase I Trial of Bispecific Anti-CD19, Anti-CD20 CAR T Cells for B Cell Malignancies
100 Clinical Results associated with Anti-CD19, Anti-CD20 CAR T Cells(Universitätsspital Basel)
Login to view more data
100 Translational Medicine associated with Anti-CD19, Anti-CD20 CAR T Cells(Universitätsspital Basel)
Login to view more data
100 Patents (Medical) associated with Anti-CD19, Anti-CD20 CAR T Cells(Universitätsspital Basel)
Login to view more data
100 Deals associated with Anti-CD19, Anti-CD20 CAR T Cells(Universitätsspital Basel)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| B-Cell Malignant Neoplasm | Phase 1 | Switzerland | 01 Nov 2025 | |
| Burkitt Lymphoma | Phase 1 | Switzerland | 01 Nov 2025 | |
| High grade B-cell lymphoma | Phase 1 | Switzerland | 01 Nov 2025 | |
| Low Grade B-Cell Non-Hodgkin's Lymphoma | Phase 1 | Switzerland | 01 Nov 2025 | |
| Marginal Zone B-Cell Lymphoma | Phase 1 | Switzerland | 01 Nov 2025 | |
| Mediastinal large B-cell lymphoma | Phase 1 | Switzerland | 01 Nov 2025 | |
| Small Lymphocytic Lymphoma | Phase 1 | Switzerland | 01 Nov 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free